Dr. Agarwal's Health Care Limited (AGARWALEYE) reported revenue of ₹614 Cr and net profit of ₹55.02 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
AGARWALEYE fundamentals, Fundamental score 58/100
The statements below are read from Dr. Agarwal's Health Care Limited’s filed results, 11 filed quarters and 7 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 5, 2026 · audited
Sales CAGR · 3Y+26.9%FY22 → FY25
Sales CAGR · 4Y+31.5%FY21 → FY25
PAT CAGR · 3Y+17.7%FY22 → FY25
PAT CAGR · 4Y+40.6%FY21 → FY25
Price · 1Y+23.8%EOD
Price CAGR · 3Y—EOD
Quarterly resultsConsolidated
₹ Cr
Dec2023
Mar2024
Jun2024
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
333
349
403
417
431
460
487
499
530
564
614
+26.0%
244
241
300
310
316
329
360
363
386
403
444
+23.4%
Operating profit
89.0
108
103
107
115
131
128
136
144
161
170
+33.3%
OPM %
26.7%
30.9%
25.6%
25.7%
26.7%
28.5%
26.2%
27.3%
27.2%
28.6%
27.8%
+1.5 pp
Other income
12.0
20.0
6.00
12.0
12.7
15.4
13.4
7.93
10.5
12.6
6.41
-52.1%
Interest
22.0
27.0
27.0
28.0
28.4
25.0
24.7
22.6
21.1
22.1
23.4
-5.4%
Depreciation
43.0
47.0
56.0
57.0
58.2
60.4
63.0
67.9
68.8
76.7
78.3
+24.4%
Profit before tax
36.0
54.0
27.0
33.0
41.0
58.5
53.6
53.7
64.8
76.6
75.1
+40.2%
Tax %
36.1%
24.1%
33.3%
36.4%
31.1%
27.3%
29.0%
32.0%
32.6%
34.8%
26.8%
-2.2 pp
Net profit
23.0
41.0
18.0
21.0
28.2
42.6
38.1
36.5
43.6
50.0
55.0
+44.6%
EPS (₹)
—
—
—
—
0.73
1.04
0.95
0.94
1.07
1.25
1.43
+50.5%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 11 quarters
RevenueNet profit
Revenue & net profit — Consolidated11 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±1.6%· EPS surprise: no estimates source· 4 earlier quarters have no dated filing on record
Q1'27filed Tue 4 Aug 13:59 · traded that sessiongap +0.5%close +2.1%
Q4'26filed Thu 21 May 18:07 · first tradeable session Fri 22 Maygap +1.4%close −0.4%
Q3'26filed Tue 3 Feb 20:35 · first tradeable session Wed 4 Febgap +2.4%close +1.0%
Q2'26filed Thu 30 Oct 19:31 · first tradeable session Fri 31 Octgap +1.2%close −2.4%
Q1'26filed Tue 12 Aug 18:03 · first tradeable session Wed 13 Auggap −0.2%close +0.4%
Q4'25filed Wed 28 May 20:43 · first tradeable session Thu 29 Maygap +2.0%close −1.6%
Q3'25filed Fri 14 Feb 19:08 · first tradeable session Mon 17 Febgap −2.1%close −3.3%
